Champalimaud Foundation / Fundação Champalimaud

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group (2021) Moreau P, Kumar SK, San Miguel J, Davies F, Zamagni E, Bahlis N, Ludwig H, et al. Journal article, Review article Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial (2021) Rugo HS, Im SA, Cardoso F, Cortes J, Curigliano G, Musolino A, Pegram MD, et al. Journal article KEYNOTE-522 Asian subgroup: Phase III study of neoadjuvant pembrolizumab (pembro) vs placebo (pbo) plus chemotherapy (chemo) followed by adjuvant pembro vs pbo for early triple-negative breast cancer (TNBC) (2020) Dent R, Cortes J, Pusztai L, Mcarthur HL, Kuemmel S, Bergh J, Denkert C, et al. Conference contribution Mesentery - a 'New' organ (2020) Coffey JC, Walsh D, Byrnes KG, Hohenberger W, Heald RJ Journal article, Review article Pembrolizumab for early triple-negative breast cancer (2020) Schmid P, Cortes J, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, et al. Journal article Acquiring and Predicting Multidimensional Diffusion (MUDI) Data: An Open Challenge (2020) Pizzolato M, Palombo M, Bonet-Carne E, Tax CM, Grussu F, Ianus A, Bogusz F, et al. Book chapter / Article in edited volumes KEYNOTE-522: Phase III study of pembrolizumab (pembro) plus chemotherapy (chemo) vs placebo (pbo) plus chemo as neoadjuvant treatment, followed by pembro vs pbo as adjuvant treatment for early triple-negative breast cancer (TNBC) (2019) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur HL, Kuemmel S, Bergh J, et al. Conference contribution Chimeric antigen receptor T-cell therapy for multiple myeloma: A consensus statement from the European Myeloma Network (2019) Moreau P, Sonneveld P, Boccadoro M, Cook G, Victoria Mateos M, Nahi H, Goldschmidt H, et al. Journal article Expert consensus on a train-the-trainer curriculum for robotic colorectal surgery (2019) Gómez Ruiz M, Alfieri S, Becker T, Bergmann M, Boggi U, Collins J, Figueiredo N, et al. Journal article Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. (2018) van der Valk MJ, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, Habr-Gama A, et al. Journal article